PML tumor suppressor protein is required for HCV production

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 592-597

  Kuroki, Misao ^a,b,c   Ariumi, Yasuo ^a,c   Hijikata, Makoto ^d   Ikeda, Masanori ^a   Dansako, Hiromichi ^a   Wakita, Takaji ^e   Shimotohno, Kunitada ^f   Kato, Nobuyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^f 1 7 1 Kohnodai   (Japan)

Author keywords

DDX5; Hepatitis C virus; INI1; Lipid droplet; PML; Tumor suppressor

Indexed keywords

LENTIVIRUS VECTOR; PML TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENETIC TRANSFECTION; HEPATITIS C VIRUS; IMMUNOFLUORESCENCE TEST; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; REPLICON; RNA INTERFERENCE; RNA SYNTHESIS; SUPERNATANT; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; WESTERN BLOTTING;

CELL LINE; CHROMOSOMAL PROTEINS, NON-HISTONE; DEAD-BOX RNA HELICASES; DNA-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; HEPACIVIRUS; HUMANS; NUCLEAR PROTEINS; RNA, VIRAL; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84872302281     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.108     Document Type: Article

References (30)

1. Kato N. Molecular virology of hepatitis C virus. Acta. Med. Okayama 2001, 55:133-159.
2. Kato N., Hijikata M., Ootsuyama Y., et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA 1990, 87:9524-9528.
3. Miyanari Y., Atsuzawa K., Usuda N., et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 2007, 9:1089-1097.
4. McGivern D.R., Lemon S.M. Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer. Annu. Rev. Pathol.: Mech. Dis. 2009, 4:399-415.
5. Herzer K., Weyer S., Krammer P.H., et al. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res. 2005, 65:10830-10837.
6. Everett R.D., Chelbi-Alix M.K. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 2007, 89:819-830.
7. Reineke E.L., Kao H.Y. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. Intl. J. Biol. Sci. 2009, 5:366-376.
8. Kuroki M., Ariumi Y., Ikeda M., et al. Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress. J. Virol. 2009, 83:2338-2348.
9. Wakita T., Pietschmann T., Kato T., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11:791-796.
10. Ariumi Y., Kuroki M., Abe K., et al. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 2007, 81:13922-13926.
11. Ariumi Y., Kuroki M., Dansako H., et al. The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication. J. Virol. 2008, 82:9639-9646.
12. Ariumi Y., Kuroki M., Kushima Y., et al. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J. Virol. 2011, 85:6882-6892.
13. Ariumi Y., Kuroki M., Maki M., et al. The ESCRT system is required for hepatitis C virus production. PLoS One 2011, 6:e14517.
14. Ikeda M., Abe K., Dansako H., et al. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem. Biophys. Res. Co. 2005, 329:1350-1359.
15. Brummelkamp T.P., Bernard R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296:550-553.
16. Bridge A.J., Pebernard S., Ducraux A., et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 2003, 34:263-264.
17. Ariumi Y., Serhan F., Turelli P., et al. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription. Retrovirology 2006, 3:47.
18. Naldini L., Blömer U., Gallay P., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
19. Zufferey R., Nagy D., Mandel R.J., et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15:871-875.
20. Lindenbach B.D., Evans M.J., Syder A.J., et al. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626.
21. Ishii K., Murakami K., Hmwe S.S., et al. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. Biochem. Biophys. Res. Co. 2008, 371:446-450.
22. Steinmann E., Brohm C., Kallis S., et al. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J. Virol. 2008, 82:7034-7046.
23. Turelli P., Doucas V., Craig E., et al. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 2001, 7:1245-1254.
24. Bates G.J., Nicol S.M., Wilson B.J., et al. The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumor suppressor. EMBO J. 2005, 24:543-553.
25. Watashi K., Hijikata M., Tagawa A., et al. Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus. Mol. Cell. Biol. 2003, 23:7498-7509.
26. Chang K.S., Jiang J., Cai Z., et al. Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture. J. Virol. 2007, 81:13783-13793.
27. Moriishi K., Shoji I., Mori Y., et al. Involvement of PA28γ in the propagation of hepatitis C virus. Hepatology 2010, 52:411-420.
28. Zannini L., Buscemi G., Fontanella E., et al. REGγ/PA28γ proteasome activator interacts with PML and Chk2 and affects PML nuclear bodies number. Cell Cycle 2009, 8:2399-2407.
29. Yung E., Sorin M., Pal A., et al. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nat. Med. 2001, 7:920-926.
30. Giorgi C., Ito K., Lin H.K., et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010, 330:1247-1251.